| Primary |
| Asthma |
47.0% |
| Drug Use For Unknown Indication |
25.3% |
| Chronic Obstructive Pulmonary Disease |
10.5% |
| Product Used For Unknown Indication |
4.8% |
| Dyspnoea |
3.3% |
| Wheezing |
1.8% |
| Bronchitis |
1.2% |
| Asthma Exercise Induced |
0.9% |
| Bronchospasm |
0.6% |
| Cough |
0.6% |
| Emphysema |
0.6% |
| Multiple Allergies |
0.6% |
| Respiratory Disorder |
0.6% |
| Asbestosis |
0.3% |
| Bronchitis Chronic |
0.3% |
| Electrolyte Substitution Therapy |
0.3% |
| Hypersensitivity |
0.3% |
| Increased Upper Airway Secretion |
0.3% |
| Lower Respiratory Tract Infection |
0.3% |
| Lung Disorder |
0.3% |
|
| Pharmaceutical Product Complaint |
22.4% |
| Product Quality Issue |
22.4% |
| Drug Ineffective |
11.0% |
| Death |
7.5% |
| Therapeutic Response Unexpected With Drug Substitution |
5.3% |
| Product Substitution Issue |
3.5% |
| Wheezing |
3.5% |
| Anaphylactic Reaction |
2.6% |
| Drug Effect Decreased |
2.6% |
| Pneumonia |
2.2% |
| Device Failure |
1.8% |
| Loss Of Consciousness |
1.8% |
| No Therapeutic Response |
1.8% |
| Quality Of Life Decreased |
1.8% |
| Reaction To Drug Excipients |
1.8% |
| Swollen Tongue |
1.8% |
| Therapeutic Product Ineffective |
1.8% |
| Vomiting |
1.8% |
| Wrong Technique In Drug Usage Process |
1.8% |
| Device Malfunction |
1.3% |
|
| Secondary |
| Asthma |
32.2% |
| Chronic Obstructive Pulmonary Disease |
14.9% |
| Drug Use For Unknown Indication |
8.0% |
| Anxiety |
6.9% |
| Dyspnoea |
5.7% |
| Pain |
4.6% |
| Gastrooesophageal Reflux Disease |
3.4% |
| Insomnia |
3.4% |
| Smoking Cessation Therapy |
3.4% |
| Product Used For Unknown Indication |
2.3% |
| Convulsion |
1.7% |
| Headache |
1.7% |
| Hypertension |
1.7% |
| Inhalation Therapy |
1.7% |
| Nausea |
1.7% |
| Vomiting |
1.7% |
| Blood Cholesterol Increased |
1.1% |
| Cough |
1.1% |
| Emphysema |
1.1% |
| Wheezing |
1.1% |
|
| Pharmaceutical Product Complaint |
14.3% |
| Drug Ineffective |
10.7% |
| Product Quality Issue |
7.1% |
| Therapeutic Response Unexpected With Drug Substitution |
7.1% |
| Vomiting |
7.1% |
| Cerebrovascular Accident |
5.4% |
| Death |
5.4% |
| Spinal Fracture |
5.4% |
| Stevens-johnson Syndrome |
5.4% |
| Asthma |
3.6% |
| Drug Effect Decreased |
3.6% |
| Dyspnoea |
3.6% |
| Emphysema |
3.6% |
| Panic Attack |
3.6% |
| Weight Increased |
3.6% |
| Wheezing |
3.6% |
| Abnormal Dreams |
1.8% |
| Chest Discomfort |
1.8% |
| Cough |
1.8% |
| Diabetic Neuropathy |
1.8% |
|
| Concomitant |
| Drug Use For Unknown Indication |
35.0% |
| Asthma |
17.6% |
| Chronic Obstructive Pulmonary Disease |
8.2% |
| Product Used For Unknown Indication |
8.1% |
| Hypertension |
4.8% |
| Depression |
3.1% |
| Pain |
2.6% |
| Gastrooesophageal Reflux Disease |
2.6% |
| Hypersensitivity |
2.6% |
| Anxiety |
2.3% |
| Diabetes Mellitus |
1.9% |
| Osteoporosis |
1.6% |
| Contraception |
1.4% |
| Blood Cholesterol Increased |
1.3% |
| Nausea |
1.3% |
| Dyspnoea |
1.2% |
| Rheumatoid Arthritis |
1.2% |
| Emphysema |
1.2% |
| Insomnia |
1.2% |
| Muscle Spasms |
1.1% |
|
| Dyspnoea |
12.8% |
| Drug Ineffective |
9.5% |
| Vomiting |
9.5% |
| Product Quality Issue |
9.1% |
| Wheezing |
7.0% |
| Nausea |
5.0% |
| Weight Decreased |
5.0% |
| Death |
4.1% |
| Rash |
4.1% |
| Type 2 Diabetes Mellitus |
3.7% |
| Urticaria |
3.7% |
| White Blood Cell Count Increased |
3.7% |
| Myocardial Infarction |
3.3% |
| Status Asthmaticus |
3.3% |
| Pharmaceutical Product Complaint |
2.9% |
| Productive Cough |
2.9% |
| Weight Increased |
2.9% |
| Chronic Obstructive Pulmonary Disease |
2.5% |
| Deep Vein Thrombosis |
2.5% |
| Dysphonia |
2.5% |
|
